ServiceNow stock outlook maintained by BTIG ahead of analyst day

ServiceNow shares fell 18% after its Q1 report and are down 53% over the past year, even as BTIG reiterated a Buy and $150 target ahead of Tuesday’s analyst day. Management raised its 2026 AI annual contract value target to $1.5 billion from $1 billion, but investors remain focused on decelerating growth, mixed subscription visibility, and a second-quarter current remaining performance obligation miss of 100 bps excluding M&A. The article also notes concern that U.S.-Iran geopolitical tensions may be weighing on quarterly subscription revenue expectations.

Analysis

The market is treating this as a simple growth deceleration story, but the more important issue is monetization quality: ServiceNow is shifting from seat-led expansion to AI-led consumption, which usually means near-term revenue recognition is noisier even if long-duration value creation improves. That transition tends to punish the stock twice — first on guidance conservatism, then again when investors realize the new AI attach is dilutive to visibility before it is accretive to ARR. The current multiple compression likely reflects not just lower growth, but a higher discount rate on forecast reliability.

The second-order winner is likely the broader enterprise AI stack, not just NOW. If ServiceNow can prove meaningful usage-based monetization, it validates budget reallocation toward workflow automation vendors with embedded AI, which would help adjacent names with similar bundling strategies and hurt point-solution AI vendors that depend on standalone spend. Conversely, if management emphasizes pack revenue is still small, the read-through is that enterprise AI remains an upsell feature rather than a budget line item, which could compress enthusiasm across the software cohort.

Geopolitical noise matters here only insofar as it widens the dispersion between “beats” and “guides.” When macro uncertainty rises, large-cap software usually trades on subscription visibility; any miss in current RPO or forward commentary gets amplified because investors are already demanding proof that AI can reaccelerate growth, not just defend it. That means the stock can stay weak for several weeks even if the analyst day is constructive, unless management gives a credible bridge from AI ACV to revenue with clear conversion timing.

The contrarian view is that the selloff may be overdone relative to the fundamental reset: the business is still growing well above most large-cap software peers, and the market may be extrapolating short-term conversion friction into a structural demand problem. If analyst day shows AI ACV is compounding and renewal behavior is improving, the stock could rerate quickly because current positioning is already skeptical. The key catalyst is not a headline AI number, but whether management can quantify the lag between deployment and monetization in a way that restores forecast confidence.

Key Decisions for Investors

• Buy NOW on weakness into/after Analyst Day only if management quantifies AI conversion timing; target a 10-15% rebound over 4-8 weeks, with a stop if they fail to bridge AI ACV to revenue visibility.
• For tactical downside, buy NOW put spreads expiring 4-6 weeks out to express continued multiple compression if guidance remains opaque; risk/reward favors defined-risk bearish exposure after a 18% post-earnings drawdown.
• Pair trade: long NOW / short a lower-quality enterprise software name with similar AI rhetoric but weaker cash generation over the next 1-2 months; the spread should work if the market rewards durable subscription quality over narrative.
• If Analyst Day is constructive, leg into calls rather than stock — implied volatility should remain elevated, and upside is likely to come from multiple expansion rather than near-term estimate revisions.
• Avoid chasing the broader software basket until NOW sets a clearer read-through on AI monetization; this is a stock-specific proof point, not yet a sector-wide reacceleration signal.